跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 763 条关于
“PT Etana Biotechnologies”
全部
763
临床试验
203
药物
228
机构
55
资讯
277
去年
Recce Pharmaceuticals' RECCE 327 Gel Receives Approval for Phase III Diabetic Foot Infection Trial in Indonesia
去年
Recce Pharmaceuticals Receives Ethics Approval in Indonesia for Phase 3 Diabetic Foot Infection Trial
去年
Recce Pharmaceuticals' RECCE 327 Topical Gel Receives Indonesian Approval for Phase 3 Diabetic Foot Infection Trial
9个月前
PT-112 Demonstrates Promising Efficacy in Recurrent Thymoma Phase 2 Trial
去年
FDA Greenlights Promontory Therapeutics' Phase 3 Trial Design for PT-112 in Metastatic Prostate Cancer
2年前
Promontory Therapeutics Completes Enrollment in Phase 2 Trial of PT-112 for Late-Stage Metastatic Prostate Cancer
去年
Momentum Biotechnologies Acquires OmicScouts to Expand Mass Spectrometry-Based Drug Discovery Platform
去年
CollPlant Advances Regenerative Breast Implant Technology with Promising Preclinical Results
11个月前
Recce Pharmaceuticals Initiates Phase 3 Trial for Novel Diabetic Foot Infection Treatment in Indonesia
去年
Argenx Expands Partnership with Fujifilm Biotechnologies to Manufacture Efgartigimod in the U.S.
第 1 页,共 28 页
上一页
下一页